First do no harm. Why healthcare needs to change

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Robert Metzke, Global Head of Sustainability, Philips If I’ve learned one thing working in the healthcare sector, it’s the earlier you can diagnose a disease, the better chance you have of curing it – or at least mitigating its […]

Reduce costs, save lives: how healthcare data can help emerging economies

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Noella Bigirimana, Government Fellow, Rwanda Ministry of Health , World Economic Forum Emerging economies are projected to surpass mature economies in overall generation of data by 2020. The volume of healthcare data, one of the fastest growing segments of […]

Concorde is a reminder that the only way for innovation is up

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Simon Freakley, Chief Executive Officer, AlixPartners I do not think I have ever met a child who is not fascinated with flying. When an airplane passes overhead and my own children look up at the sky, I can remember […]

We can end TB right now. Here’s how

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Paul Stoffels, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson In 2014, the world experienced the first-ever major Ebola epidemic. Over the following two years, nearly 30,000 Ebola cases were reported. More than 11,000 […]

The EU clears Bayer-Monsanto merger amid wide competition and environmental concerns

Bayer’s cross at night (Copyright: Bayer AG)

Last week, the European Union formally gave its approval to Germany multinational company Bayer’s $62.5 billion acquisition of US-based Monsanto. Bayer AG, leader in the chemical and pharmaceutical industry, got one step closer to take over the world’s largest seed company, after agreeing to bolster BASF SE by selling to it seeds, pesticides and digital […]

Is there a drug for every disease?

Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]